Business context and reporting period
This filing is for Vectrus, Inc. (NYSE: VEC), a U.S. government services contractor, for the quarter ended October 2, 2020, and the first nine months of 2020. The requested company name, V2X, Inc., does not match the registrant named in the filing; confirm the intended issuer.
Vectrus provides base and facility operations, logistics, IT mission support, and engineering and digital technology services. Substantially all revenue came from U.S. Government customers; the U.S. Army generated about 68% of nine-month revenue.
Financial performance
| Metric | Q3 2020 | Q3 2019 | Nine months 2020 | Nine months 2019 |
|---|---|---|---|---|
| Revenue | $352.4 million | $359.9 million | $1,040.2 million | $1,017.4 million |
| Operating income | $14.8 million | $12.4 million | $29.8 million | $34.0 million |
| Operating margin | 4.2% | 3.5% | 2.9% | 3.3% |
| Net income | $10.4 million | $7.8 million | $20.2 million | $22.5 million |
| Diluted EPS | $0.88 | $0.67 | $1.72 | $1.95 |
| Operating cash flow | Not separately provided | Not separately provided | $37.7 million | $28.4 million |
For the nine months, revenue rose 2.2%, while operating income fell 12.5% and net income fell 10.5%. Cost of revenue increased to 91.5% of revenue from 90.8%; cumulative contract-estimate adjustments reduced operating income by $3.8 million, versus a $1.5 million benefit in the prior-year period. Q3 net income increased 32.5%, with lower SG&A and interest expense contributing to improved results.
Cash was $63.7 million at October 2, 2020, including $17.6 million held by foreign subsidiaries. Current assets were $356.4 million and current liabilities $247.2 million. Balance-sheet debt was approximately $65.3 million, including $8.0 million short-term debt and $57.3 million long-term debt, net. Management reported net debt of $2.3 million. The revolver had no borrowings and $117.6 million of available capacity after letters of credit. The company reported compliance with its debt covenants.
Nine-month investing cash outflow was $3.3 million, versus $53.0 million in 2019, which included the Advantor acquisition. The company repaid $4.5 million of term debt. CARES Act tax deferrals contributed $9.9 million to operating cash flow.
Material changes versus comparable periods
- Q3 revenue declined 2.1%, reflecting lower Middle East and European activity, partly offset by growth in U.S. programs. Management attributed the decrease primarily to COVID-19-related disruption.
- Nine-month revenue increased 2.2%, led by U.S. program growth, but margins and operating income declined, particularly in Middle East programs.
- Firm-fixed-price revenue increased 18.2% in Q3 and 23.4% year to date; cost-plus and cost-reimbursable revenue fell 8.6% and 4.2%, respectively.
- Total backlog increased to $3.742 billion from $2.751 billion at year-end 2019. Funded backlog was $1.057 billion; unfunded backlog was $2.685 billion. Funded orders received in the first nine months were $1.588 billion.
- The filing restates applicable prior-period figures for contract cost-estimation and historical overbilling errors. The cumulative effect reduced December 31, 2019 retained earnings by $2.5 million; management concluded the prior-period errors were not material.
Outlook, risks and unusual items
Management estimated COVID-19 reduced Q3 revenue by $12.9 million and diluted EPS by $0.14; the estimated nine-month effects were $37.3 million and $0.30 per share. Causes included restrictions on access to certain bases and supplier delays. The ultimate effects remained uncertain. Management said cash, operating cash flow and available revolver capacity were expected to cover anticipated needs for at least 12 months.
The company expected to recognize about 30% of its $1.156 billion of remaining performance obligations in 2020 and 70% in 2021. This is not equivalent to total backlog: backlog includes unfunded orders and options, and contract options may not be exercised. No specific earnings or revenue guidance was provided in the supplied filing text.
Key risks include pandemic-related operating and workforce disruption, U.S. Government budget and funding decisions, contract renewals and protests, audit adjustments, and reliance on a concentrated customer base. The continuing resolution then in effect funded federal agencies through December 11, 2020. K-BOSSS represented 33.3% of nine-month revenue and was exercised through September 28, 2021; OMDAC-SWACA represented 15.2% and was exercised through February 28, 2021. One appeal concerning the LOGCAP V award remained pending, though management said it had not affected transition or performance.
The company accrued $11.6 million for legal proceedings and government-contract claims and did not expect the matters to materially affect its financial condition, results or cash flows. Unrecognized tax benefits were $12.5 million, up from $7.9 million at year-end, principally due to an additional FDII deduction. Goodwill was $262.1 million; a COVID-related qualitative assessment found impairment was not more likely than not as of October 2, 2020.
Important facts for investors to verify
- Confirm whether the intended issuer is Vectrus, Inc. (VEC), as named in the filing, or V2X, Inc.
- Review the restated 2019 financial statements and the effects of the contract-cost and overbilling corrections.
- Assess whether reported backlog converts to funded work and revenue, including the exercise of options and the outcome of contract protests.
- Track COVID-19 effects, contract-estimate adjustments, and margin trends, especially on Middle East programs and fixed-price work.
- Reconcile management’s reported $2.3 million net debt with the balance-sheet debt and cash amounts and its definition of net debt.
- Monitor the continuing resolution, major contract periods, government audits and claims, and availability of U.S. and foreign cash.